Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Feasibility and Usability Study of HemoScreen Hematology Analyzer for Cancer Patients Receiving Chemo and Its Potential for Home Monitoring of Blood Values Before Chemotherapy

NCT04543734 is registered in ClinicalTrials.gov with Niels Henrik Holländer as lead sponsor.

NCT NCT04543734
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04543734 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Feasibility and Usability Study of HemoScreen Hematology Analyzer for Cancer Patients Receiving Chemo and Its Potential for Home Monitoring of Blood Values Before Chemotherapy
Lead sponsor
Niels Henrik Holländer
Phase
Observational
Overall status
Completed
Start date
September 11, 2020
Completion date
October 31, 2022
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer